Y. Shen

1052PDNIVOLUMAB (N) (ANTI-PD-1; BMS-936558, ONO-4538) IN COMBINATION WITH SUNITINIB (S) OR PAZOPANIB (P) IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC).

E. Plimack, M. Voss, B. Rini, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

ENTRATA: Randomized, double-blind, phase II study of telaglenastat (tela; CB-839) + everolimus (E) vs placebo (pbo) + E in patients (pts) with advanced/metastatic renal cell carcinoma (mRCC)

R. Motzer, J. Hsieh, A. Hussain, 2019, Annals of Oncology.

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

Y. Chen, J. You, L. Wang, 2007, Annals of Hematology.

1050OPHASE I STUDY OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN METASTATIC RENAL CELL CARCINOMA (MRCC).

E. Plimack, M. Voss, B. Rini, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Common Polymorphisms in the CACNA1H Gene Associated with Childhood Absence Epilepsy in Chinese Han Population

Y. Jiang, Y. Zhang, Y. Jiang, 2007, Annals of human genetics.

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

T. Greiner, J. Vose, M. Piris, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

1175OEGFR MUTATION AND SURVIVAL OUTCOMES IN PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA - A MULTIPLE CENTERS, NON-INTERVENTIONAL STUDY (ICAN TRIAL).

Q. Wang, Y. Wu, Y. Liu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.